HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain
Qingfu Deng(Chongqing Medical University), Xiaohou Wu(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 5
Related Papers
PLCε promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathway‑mediated glycolysis
|Oncology Reports|2019|20